A Prolonged Follow-Up on the Efficacy and Safety of Infliximab Biosimilar CT-P13 in IBD Across Italy: The Prosit Cohort

Authors :: Francesco William Guglielmi
Angela Variola
Arnaldo Amato
Angelo Andriulli
Mariabeatrice Principi
Maria M. Terpin
Francesca Rogai
Renata D'Incà
Silvio Danese
Maria Laura Annunziata
Fabrizio Bossa
Roberto Tari
Fabiana Castiglione
Laura Cantoro
Antonio Di Sabatino
Maria Di Girolamo
Alessandro Armuzzi
Claudio Camillo Cortelezzi
R. Caccaro
Natalia Manetti
Gionata Fiorino
Luisa Guidi
Carlo Petruzzellis
Anna Kohn
Walter Fries
Francesco Costa
Livia Biancone
Ambrogio Orlando
G. Meucci
Giulia Rizzuto
Simone Saibeni
Agostino Ventra
Edoardo Troncone
Maria Cappello
B. Scrivo
Andrea Geccherle
Daniela Pugliese
Olga Maria Nardone
Vito Annese
Armuzzi, A
Fiorino, G
Variola, A
Manetti, N
Fries, W
Rizzuto, G
Bossa, F
Cappello, M
Biancone, L
D'Inca, R
Cantoro, L
Castiglione, F
Principi, M
Annunziata, Ml
Di Girolamo, M
Terpin, Mm
Cortelezzi, Cc
Costa, F
Amato, A
Di Sabatino, A
Saibeni, S
Meucci, G
Petruzzellis, C
Tari, R
Guglielmi, Fw
Guidi, L
Danese, S
Rogai, F
Geccherle, A
Ventra, A
Orlando, A
Andriulli, A
Scrivo, B
Troncone, E
Caccaro, R
Kohn, A
Nardone, Om
Pugliese, D
Annese, V
Source :: Gastroenterology. 152:S108
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
Biosimilar
Pharmacology
Infliximab
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Cohort
medicine
business
medicine.drug

Tools